Rheumatoid arthritis (RA) is a systemic inflammatory condition. Its classic presentation is as an insidious inflammatory polyarthropathy with associated synovitis, pain and eventually joint deformity and destruction. Early diagnosis and treatment is crucial in minimising long-term morbidity and mortality. Therefore, GPs need to identify and appropriately refer those suspected of having RA. This article summarises the role of the GP in the management of RA.
CollinsG. S.AltmanD. G. (2010) An independent and external validation of QRISK2 cardiovascular disease risk score: A prospective open cohort study. British Medical Journal340: c2442doi: 10.1136/bmj.c2442.
DeightonC.O'MahonyR.ToshJ.TurnerC.RudolfM. (2009) Management of rheumatoid arthritis: Summary of NICE guidance. British Medical Journal338: b702doi: 10.1136/bmj.b702.
7.
DingT.LedinghamJ.LuqmaniR.WestlakeS.HyrichK.LuntM.DeightonC. (2010) BSR and BHPR rheumatoid arthritis guidelines on safety of anti - TNF therapies. Rheumatology (Oxford)49(11): 2217–2219. doi: 10.1093/rheumatology/keq249a.
8.
FRAX. (2014). WHO fracture risk assessment tool. Retrieved from www.shef.ac.uk/FRAX/.
KumarK.DaleyE.CarruthersD. M.SitunayakeD.GordonC.GrindulisK.RazaK. (2007) Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists. Rheumatology (Oxford)46(9): 1438–1440. doi: 10.1093/rheumatology/kem130.
11.
NaredoE.ColladoP.CruzA.PalopM. J.CaberoF.RichiP.CrespoM. (2007) Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: Predictive value in disease activity and radiologic progression. Arthritis & Rheumatism57(1): 116–124. doi: 10.1002/art.22461.
12.
NICE. (2007). Adalimumab, ertanercept and infliximab for the treatment of rheumatoid arthritis. Retrieved from www.nice.org.uk/guidance/TA130.
13.
NICE. (2009). The management of rheumatoid arthritis in adults. Retrieved from www.nice.org.uk/CG79.
14.
RazaK. (2010) The Michael Mason prize: Early rheumatoid arthritis–the window narrows. Rheumatology (Oxford)49(3): 406–410. doi: 10.1093/rheumatology/kep392.
SmolenJ. S.LandeweR.BreedveldF. C.BuchM.BurmesterG.DougadosM.van der HeijdeD. (2014) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Annals of Rheumatic Disease73(3): 492–509. doi: 10.1136/annrheumdis-2013-204573.
19.
SuterL. G.FraenkelL.HolmboeE. S. (2006) What factors account for referral delays for patients with suspected rheumatoid arthritis?Arthritis and Rheumatism55(2): 300–305. doi: 10.1002/art.21855.